| Primary |
| Drug Use For Unknown Indication |
19.7% |
| Muscle Spasticity |
15.2% |
| Pain |
9.1% |
| Hypertension |
7.6% |
| Intentional Overdose |
6.1% |
| Back Pain |
4.5% |
| Bone Pain |
3.0% |
| Gastrooesophageal Reflux Disease |
3.0% |
| Intervertebral Disc Protrusion |
3.0% |
| Multiple Sclerosis |
3.0% |
| Muscle Disorder |
3.0% |
| Muscle Relaxant Therapy |
3.0% |
| Muscle Spasms |
3.0% |
| Osteoarthritis |
3.0% |
| Parkinson's Disease |
3.0% |
| Pneumonia Bacterial |
3.0% |
| Surgery |
3.0% |
| Arthralgia |
1.5% |
| Benign Prostatic Hyperplasia |
1.5% |
| Brachial Plexopathy |
1.5% |
|
| Vomiting |
17.9% |
| Syncope |
10.7% |
| Somnolence |
7.1% |
| Tachycardia |
7.1% |
| Anaphylactic Shock |
3.6% |
| Cerebrovascular Accident |
3.6% |
| Drug Abuser |
3.6% |
| Dyspnoea |
3.6% |
| Hyperkinesia |
3.6% |
| Hypoglycaemia |
3.6% |
| Hypotension |
3.6% |
| Intestinal Obstruction |
3.6% |
| Localised Oedema |
3.6% |
| Myocardial Infarction |
3.6% |
| Respiratory Distress |
3.6% |
| Restlessness |
3.6% |
| Sedation |
3.6% |
| Sensory Disturbance |
3.6% |
| Sopor |
3.6% |
| Spinal Cord Compression |
3.6% |
|
| Secondary |
| Pain |
23.8% |
| Product Used For Unknown Indication |
8.6% |
| Psoriatic Arthropathy |
8.6% |
| Back Pain |
7.9% |
| Multiple Sclerosis |
7.9% |
| Spinal Cord Disorder |
7.9% |
| Muscle Spasticity |
6.0% |
| Essential Hypertension |
4.6% |
| Muscle Spasms |
3.3% |
| Neck Pain |
3.3% |
| Hypertension |
2.6% |
| Intentional Overdose |
2.6% |
| Muscle Contractions Involuntary |
2.6% |
| Diabetes Mellitus |
2.0% |
| Arteriosclerosis |
1.3% |
| Bone Pain |
1.3% |
| Contraception |
1.3% |
| Depression |
1.3% |
| Dizziness |
1.3% |
| Epilepsy |
1.3% |
|
| Vomiting |
12.5% |
| Muscular Weakness |
9.4% |
| Pyrexia |
9.4% |
| Eyelid Oedema |
6.3% |
| Pregnancy On Oral Contraceptive |
6.3% |
| Somnolence |
6.3% |
| Sopor |
6.3% |
| Tachycardia |
6.3% |
| Anaemia |
3.1% |
| Balance Disorder |
3.1% |
| Cerebrovascular Accident |
3.1% |
| Convulsion |
3.1% |
| Drug Interaction |
3.1% |
| Hepatic Enzyme Increased |
3.1% |
| Hypertension |
3.1% |
| Hypoglycaemia |
3.1% |
| Muscle Contractions Involuntary |
3.1% |
| Muscle Contracture |
3.1% |
| Pancreatitis Acute |
3.1% |
| Pseudomembranous Colitis |
3.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
17.2% |
| Multiple Sclerosis |
13.8% |
| Muscle Spasticity |
8.3% |
| Osteoporosis |
7.2% |
| Prophylaxis |
7.0% |
| Drug Use For Unknown Indication |
5.9% |
| Pain |
5.3% |
| Hypertension |
5.1% |
| Depression |
4.9% |
| Relapsing-remitting Multiple Sclerosis |
4.4% |
| Trigeminal Neuralgia |
3.0% |
| Essential Hypertension |
2.5% |
| Muscle Spasms |
2.5% |
| Neuralgia |
2.3% |
| Back Pain |
2.1% |
| Diabetes Mellitus |
1.9% |
| Hypothyroidism |
1.7% |
| Insomnia |
1.7% |
| Non-small Cell Lung Cancer |
1.7% |
| Anxiety |
1.5% |
|
| Syncope |
12.7% |
| Recall Phenomenon |
8.9% |
| Vomiting |
8.9% |
| Progressive Multifocal Leukoencephalopathy |
7.6% |
| Hypotension |
6.3% |
| Pyrexia |
6.3% |
| Thirst Decreased |
5.1% |
| Drug Interaction |
3.8% |
| Hepatic Enzyme Increased |
3.8% |
| Impaired Healing |
3.8% |
| Malignant Melanoma |
3.8% |
| Nausea |
3.8% |
| Pancreatitis Acute |
3.8% |
| Rhabdomyolysis |
3.8% |
| Thrombocytopenia |
3.8% |
| Vision Blurred |
3.8% |
| Basal Cell Carcinoma |
2.5% |
| Chronic Obstructive Pulmonary Disease |
2.5% |
| Deep Vein Thrombosis |
2.5% |
| Dermatitis Allergic |
2.5% |
|
| Interacting |
| Drug Use For Unknown Indication |
50.0% |
| Multiple Sclerosis |
16.7% |
| Muscle Spasticity |
16.7% |
| Pain |
16.7% |
|
| Hepatic Enzyme Increased |
50.0% |
| Respiratory Distress |
50.0% |
|
